KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.500 $0.720 Friday, 26th Apr 2024 ADXS stock ended at $0.555. This is 0.91% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 0.91% from a day low at $0.550 to a day high of $0.555.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Apr 26, 2024 $0.550 $0.555 $0.550 $0.555 464
Apr 25, 2024 $0.550 $0.550 $0.550 $0.550 426
Apr 24, 2024 $0.540 $0.540 $0.540 $0.540 148
Apr 23, 2024 $0.512 $0.540 $0.512 $0.540 886
Apr 22, 2024 $0.572 $0.572 $0.572 $0.572 188
Apr 19, 2024 $0.600 $0.600 $0.572 $0.572 2 462
Apr 18, 2024 $0.571 $0.571 $0.500 $0.570 9 360
Apr 17, 2024 $0.650 $0.650 $0.640 $0.646 2 242
Apr 16, 2024 $0.685 $0.685 $0.591 $0.601 4 865
Apr 15, 2024 $0.668 $0.668 $0.607 $0.621 6 112
Apr 12, 2024 $0.668 $0.668 $0.610 $0.668 4 675
Apr 11, 2024 $0.668 $0.668 $0.660 $0.668 2 928
Apr 10, 2024 $0.610 $0.610 $0.610 $0.610 703
Apr 09, 2024 $0.610 $0.610 $0.610 $0.610 731
Apr 08, 2024 $0.668 $0.668 $0.668 $0.668 1 209
Apr 05, 2024 $0.687 $0.700 $0.607 $0.607 10 176
Apr 04, 2024 $0.670 $0.670 $0.607 $0.607 2 638
Apr 03, 2024 $0.640 $0.650 $0.627 $0.627 3 095
Apr 02, 2024 $0.640 $0.650 $0.640 $0.640 2 736
Apr 01, 2024 $0.640 $0.640 $0.640 $0.640 0
Mar 28, 2024 $0.720 $0.720 $0.640 $0.640 16 416
Mar 27, 2024 $0.610 $0.700 $0.536 $0.700 23 871
Mar 26, 2024 $0.622 $0.710 $0.580 $0.710 24 117
Mar 25, 2024 $0.626 $0.630 $0.626 $0.630 4 276
Mar 22, 2024 $0.659 $0.659 $0.535 $0.600 1 831
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT